Evidence map›Paper›PMID 31750446›Full record

ArticleMedicine and pharmacy reports2019

Paraneoplastic hypereosinophilia in a patient with peripheral T cell lymphoma, not otherwise specified.

Minodora Desmirean, Dalma Deak, Ioana Rus, Delia Dima, Sabina Iluta, Alexandra Preda, Tiberiu Moldovan, Andrei Roman, Ciprian Tomuleasa, Bobe Petrushev

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Medicine and pharmacy reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Minodora DesmireanDepartment of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Dalma DeakDepartment of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Ioana RusDepartment of Hematology, Ion Chiricuta Oncology Institute, Cluj- Napoca, Romania.
Delia DimaDepartment of Hematology, Ion Chiricuta Oncology Institute, Cluj- Napoca, Romania.
Sabina IlutaDepartment of Hematology, Ion Chiricuta Oncology Institute, Cluj- Napoca, Romania.
Alexandra PredaDepartment of Medical Oncology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.
Tiberiu MoldovanDepartment of Medical Oncology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.
Andrei RomanDepartment of Radiology, Ion Chiricuta Oncology Institute, Cluj- Napoca, Romania.
Ciprian TomuleasaDepartment of Hematology, Ion Chiricuta Oncology Institute, Cluj- Napoca, Romania.
Bobe PetrushevDepartment of Pathology, Regina Maria Laboratory, Cluj-Napoca, Romania.
Institute of Oncology Prof. Dr. Ion Chiricuta · ROIuliu Hațieganu University of Medicine and Pharmacy · ROInstitutul Regional de Gastroenterologie Prof. Dr. Octavian Fodor · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Under normal physiological conditions, the bone marrow (BM) will have between 1% and 6% eosinophils, translating into a peripheral count of 0.05 - 0.5 ×10

Indexed as

hypereosinophiliaparaneoplastic syndromeperipheral T cell lymphoma - NOS

Identifiers

PMID31750446
PMCPMC6853052
OpenAlexW2976800027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.